DigestRedComo funciona
Red
/
Empresas
Br
No verificado

Bristol Myers Squibb

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

144 Comunicados de prensa

Ver todos los comunicados de prensa
08/06/2026
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
02/06/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
01/06/2026
Cardiología
Infancia
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Ciencia
Ir de compras
Jóvenes
Medicina - Varios
Industria
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
01/06/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
29/05/2026
Eventos
Industria
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
27/05/2026
Salud
Sanidad
Ciencia
Farmacéutica
Biotecnología
Eventos
Web y redes sociales
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
21/05/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Ferias y Congresos
Industria
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
20/05/2026
Industria
Ciencia
Técnica
Software
Biotecnología
Farmacéutica
Salud
Mercado laboral
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
08/05/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
06/05/2026
Eventos
Web y redes sociales
Biotecnología
Salud
Ciencia
Farmacéutica
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0